Literature DB >> 30560363

Impact of subcutaneous tunnels on peripherally inserted catheter placement: a multicenter retrospective study.

Il Jung Kim1, Dong Jae Shim2, Jae Hwan Lee3, Eung Tae Kim4,5, Jong Hyun Byeon6, Hun Jae Lee7, Soon Gu Cho8.   

Abstract

OBJECTIVE: To evaluate the impact of subcutaneous tunneling on peripherally inserted central catheter (PICC) placement in terms of central line-associated bloodstream infections (CLABSIs).
METHODS: Our dual-facility central institutional review board approved this retrospective study. We compared 302 of 327 consecutive recipients (mean age [± SD], 68.0 ± 15.9 years; men, 134; women, 168) of tunneled PICCs (October 2017 to May 2018) with 309 of 328 consecutive recipients (mean age, 68.7 ± 14.6 years; men, 142; women, 167) of conventional PICCs (April 2016 to September 2017). Tunnels were made near puncture sites (~ 1 in. away) using hemostats or puncture needles. In each group, procedure times and rates of complications, including CLABSI, entry-site infection, dislocation, thrombophlebitis, and occlusion, were examined. Risk factors for CLABSI were analyzed via logistic and Cox regression models.
RESULTS: Subcutaneous tunnels were achieved in all patients, enabling successful peripheral vein cannulations. Group procedure times were similar (p = 0.414). CLABSI proved to be significantly less frequent after tunneling (8/6972 catheter-days) than after conventional (28/7574 catheter-days) PICC placement (adjusted hazard ratio = 0.328; 95% confidence interval, 0.149-0.721). Other risk factors (i.e., age, gender, comorbidity, PICC duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with CLABSI.
CONCLUSIONS: Compared with conventional means, a subcutaneous tunneling approach for PICC placement significantly reduces the rate of CLABSI. KEY POINTS: • Subcutaneous tunnels created to place peripherally inserted central catheters significantly reduced catheter-associated bloodstream infections. • Subcutaneous tunnel creation did not significantly prolong procedural time. • There were no subcutaneous tunnel-related complications.

Entities:  

Keywords:  Catheter-related infections; Catheterizations; Central venous catheter; PICC placement; Peripheral

Mesh:

Year:  2018        PMID: 30560363     DOI: 10.1007/s00330-018-5917-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  16 in total

1.  Peripherally inserted tunnelled catheters: a new option for venous access.

Authors: 
Journal:  Minim Invasive Ther Allied Technol       Date:  2001-07       Impact factor: 2.442

Review 2.  The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis.

Authors:  Vineet Chopra; John C O'Horo; Mary A M Rogers; Dennis G Maki; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2013-07-26       Impact factor: 3.254

3.  Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials.

Authors:  A G Randolph; D J Cook; C A Gonzales; C Brun-Buisson
Journal:  Crit Care Med       Date:  1998-08       Impact factor: 7.598

4.  Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units.

Authors:  Mark Gunst; Kazuhide Matsushima; Sue Vanek; Richard Gunst; Shahid Shafi; Heidi Frankel
Journal:  Surg Infect (Larchmt)       Date:  2010-07-14       Impact factor: 2.150

5.  PICC-associated bloodstream infections: prevalence, patterns, and predictors.

Authors:  Vineet Chopra; David Ratz; Latoya Kuhn; Tracy Lopus; Carol Chenoweth; Sarah Krein
Journal:  Am J Med       Date:  2014-01-17       Impact factor: 4.965

6.  Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial.

Authors:  J F Timsit; F Bruneel; C Cheval; M F Mamzer; M Garrouste-Orgeas; M Wolff; B Misset; S Chevret; B Regnier; J Carlet
Journal:  Ann Intern Med       Date:  1999-05-04       Impact factor: 25.391

7.  Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit.

Authors:  Sonali Advani; Nicholas G Reich; Arnab Sengupta; Leslie Gosey; Aaron M Milstone
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

8.  Peripherally Inserted Central Catheter-Related Infections in a Cohort of Hospitalized Adult Patients.

Authors:  Caroline Bouzad; Sandrine Duron; Aurore Bousquet; François-Xavier Arnaud; Laura Valbousquet; Gabrielle Weber-Donat; Christophe Teriitehau; Jacques Baccialone; Julien Potet
Journal:  Cardiovasc Intervent Radiol       Date:  2015-07-23       Impact factor: 2.740

Review 9.  Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients.

Authors:  Nasia Safdar; Dennis G Maki
Journal:  Chest       Date:  2005-08       Impact factor: 9.410

10.  Complication rates among cancer patients with peripherally inserted central catheters.

Authors:  Louise J Walshe; Sharp F Malak; Janet Eagan; Kent A Sepkowitz
Journal:  J Clin Oncol       Date:  2002-08-01       Impact factor: 44.544

View more
  2 in total

1.  Subcutaneous tunneling technique to improve outcomes for patients undergoing chemotherapy with peripherally inserted central catheters: a randomized controlled trial.

Authors:  Mao-Fang Xiao; Cai-Qiong Xiao; Jia Li; Can Dai; Yu-Ying Fan; Hui-Jiao Cao; Hui-Ying Qin
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

2.  Subcutaneous tunnelling versus conventional insertion of peripherally inserted central catheters in hospitalized patients (TUNNEL-PICC): a study protocol for a randomized controlled trial.

Authors:  Yohan Kwon; Eung Tae Kim; Soo Buem Cho; Jae Hwan Lee; Dong Jae Shim
Journal:  Trials       Date:  2022-09-15       Impact factor: 2.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.